Abstract
Catecholamine neurotransmitters are crucial molecules for physiological processes in human metabolism and are involved in the progression of various neurological diseases. Conventional analytical methods for their determination are based on time-consuming and laboratory intensive procedures. Hence, a rapid and simple method for the detection of these key brain chemicals is important to improve the human health and individual quality of life. This can also be helpful to diagnose neurological disorders at an early stage and to prevent them. In this paper, a brief overview is presented on the latest developments and applications of electrochemical sensors based on nanostructured tin dioxide (SnO2) for monitoring some of the most important catecholamine neurotransmitter substances, i.e. dopamine, epinephrine, and norepinephrine. The potential of these novel electrochemical devices and their outstanding performances in the field are highlighted.
Keywords: Neurotransmitters, catecholamine, nanostructured materials, tin oxide (SnO2), electrochemical sensor, dopamine, epinephrine, norepinephrine.
Graphical Abstract
Mini-Reviews in Organic Chemistry
Title:Detection of Catecholamine Neurotransmitters by Nanostructured SnO2-Based Electrochemical Sensors: A Review of Recent Progress
Volume: 15 Issue: 5
Author(s): N. Lavanya, S.G. Leonardi*, C. Sekar, S. Ficarra, A. Galtieri, E. Tellone and G. Neri
Affiliation:
- Department of Engineering, University of Messina, 98166, Messina,Italy
Keywords: Neurotransmitters, catecholamine, nanostructured materials, tin oxide (SnO2), electrochemical sensor, dopamine, epinephrine, norepinephrine.
Abstract: Catecholamine neurotransmitters are crucial molecules for physiological processes in human metabolism and are involved in the progression of various neurological diseases. Conventional analytical methods for their determination are based on time-consuming and laboratory intensive procedures. Hence, a rapid and simple method for the detection of these key brain chemicals is important to improve the human health and individual quality of life. This can also be helpful to diagnose neurological disorders at an early stage and to prevent them. In this paper, a brief overview is presented on the latest developments and applications of electrochemical sensors based on nanostructured tin dioxide (SnO2) for monitoring some of the most important catecholamine neurotransmitter substances, i.e. dopamine, epinephrine, and norepinephrine. The potential of these novel electrochemical devices and their outstanding performances in the field are highlighted.
Export Options
About this article
Cite this article as:
Lavanya N., Leonardi S.G.*, Sekar C., Ficarra S., Galtieri A., Tellone E. and Neri G., Detection of Catecholamine Neurotransmitters by Nanostructured SnO2-Based Electrochemical Sensors: A Review of Recent Progress, Mini-Reviews in Organic Chemistry 2018; 15 (5) . https://dx.doi.org/10.2174/1570193X15666180220144847
DOI https://dx.doi.org/10.2174/1570193X15666180220144847 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biochemical and Histochemical Comparison of Cholinesterases in Normal and Alzheimer Brain Tissues
Current Alzheimer Research Effect of Electromagnetic Field on the Polymerization of Microtubules Extracted from Rat Brain
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) PSEN1 Promoter Demethylation in Hyperhomocysteinemic TgCRND8 Mice is the Culprit, not the Consequence
Current Alzheimer Research Biochemical Strategies to Anticoagulation: A Comparative Overview
Current Vascular Pharmacology Editorial (Hot Topic :Treatment with Antidepressants)
Current Pharmaceutical Design The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory
Current Pharmaceutical Design GHB – Induced Cognitive Deficits During Adolescence and the Role of NMDA Receptor
Current Neuropharmacology The Guanylyl Cyclase Inhibition by MB as Vasoplegic Circulatory Shock Therapeutical Target
Current Drug Targets Web Service Composition Survey: State of the Art Review
Recent Patents on Computer Science Cytochrome P450 2A6 Phenotyping Based on Dietary Caffeine Intake in a Japanese Population of Non-smokers
Drug Metabolism Letters Characteristic of Cyclodextrins: Their Role and Use in the Pharmaceutical Technology
Current Drug Targets Glycogen Synthase Kinase-3 - An Overview of An Over-Achieving Protein Kinase
Current Drug Targets Clinical Characteristics and Treatment of Cardiomyopathies in Children
Current Cardiology Reviews Leukocyte Function-Associated Antigen-1: Structure, Function and Application Prospects
Protein & Peptide Letters Editorial [Hot Topic:Advances in Alzheimer Therapy: Understanding Pharmacological Approaches to the Disease (Guest Editors: Ana Martinez, Debomoy K. Lahiri, Ezio Giacobini and Nigel H. Greig)]
Current Alzheimer Research Berberine Alleviates Amyloid-beta Pathogenesis Via Activating LKB1/AMPK Signaling in the Brain of APP/PS1 Transgenic Mice
Current Molecular Medicine Fatty Acid Amide Hydrolase: A Potential Target for Next Generation Therapeutics
Current Pharmaceutical Design Targeted Therapy for Advanced Renal Cell Cancer: Cytokines and Beyond
Current Pharmaceutical Design The Pharmacology of Human Appetite Expression
Current Drug Targets Hydrogel Based Drug Delivery Systems: A Review with Special Emphasis on Challenges Associated with Decontamination of Hydrogels and Biomaterials
Current Drug Delivery